Pharmacoflash / Posters Modérés (PM2) - Oncologie
mercredi 12 juin 2024
Sessions posters
Sessions de posters modérés
•
S33
•
10h00
>
11h00
•
Pharmacoflash / Posters Modérés (PM2) - Oncologie
•
B121
Sessions de posters modérés
Modérateurs : Joe-Elie SALEM (Paris), Joachim ALEXANDRE (Caen)
Posters modérés
•
350
•
PM2-015 - Predicting high-dose methotrexate elimination using a Bayesian approach based on imprecise routine information
>
C.
Cyril
LEVEN
•
138
•
PM2-016 - Second primary cancers and hormonal therapy in prostate cancer: a French population-based study (the SCHNAPs study).
>
L-M.
Lucie-Marie
Scailteux
•
129
•
PM2-017 - Relationship between early exposure to imatinib and early molecular response in chronic myeloid leukemia
>
F.
Florian
Lemaitre
•
225
•
PM2-018 - Antiangiogenic drugs and the risk of arterial dissection or aneurysm in patients with metastatic colorectal cancer
>
P.
Pernelle
Noize
•
347
•
PM2-019 - The ONCO-FIT functional precision medicine platform: Integrative evaluation of tumor molecular alterations in cancer patient’s management
>
B.
Baptiste
Louveau
•
198
•
PM2-020 - Erythroblastopenia induced by immune checkpoint inhibitors: case series, pharmacovigilance data and review of the literature
>
J-L.
Jean-Luc
Faillie
|